ArticleNature communications2019

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.

Katherine A Michaelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.